GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Biogen Idec Inc (BIIB) [hlAlert]

Rating:
Outperform
BIIB
up 0.09 %

Biogen Idec Inc (BIIB) upgraded to Outperform with price target $382 by Robert W. Baird

Posted on: Wednesday,  Oct 22, 2014  1:25 PM ET by Robert W. Baird

Robert W. Baird rated Outperform Biogen Idec Inc (NASDAQ: BIIB) on 10/22/2014, when the stock price was $304.21.
Since then, Biogen Idec Inc has gained 0.09% as of 01/07/2016's recent price of $304.49.
If you would have followed this Robert W. Baird's recommendation on BIIB, you would have gained 0.09% of your investment in 442 days.

Biogen Idec Inc. is engaged in the development, manufacturing, and commercialization of therapies. The Company?s products address diseases such as multiple sclerosis, non-Hodgkin?s lymphoma (NHL), rheumatoid arthritis (RA), crohn?s disease (CD) and psoriasis. The Company has four products: AVONEX (interferon beta-1a), RITUXAN (rituximab), TYSABRI (natalizumab) and FUMADERM (dimethylfumarate and monoethylfumarate salts). AVONEX is used in the treatment of relapsing forms of multiple sclerosis (MS). RITUXAN is one of the selling oncology therapeutics. In the United States, RITUXAN is approved for NHL. TYSABRI is approved for the treatment of relapsing forms of MS. FUMADERM acts as an immunomudulator. The Company also has product candidates, such as BG-12, which is a oral fumarate; ANTI-CD80 monoclonal antibody (MAb)(galiximab); ANTI-CD23 MAb (lumiliximab); Humanized Anti-CD20 MAb (ocrelizumab), Lixivaptan, an oral compound for the potential treatment of hyponatremia, and ADENTRI.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/22/2014 1:25 PM Buy
None
304.21 382.00
as of 8/27/2015
1 Week down  -1.45 %
1 Month down  -26.85 %
3 Months down  -22.78 %
1 YTD up  0.09 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/6/2009 9:25 AM Hold
None
51.02 50.00
11/3/2008 8:25 AM Buy
None
45.10 55.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy